资讯

IIMA plans to establish an international campus in Dubai, offering a one-year MBA program for global professionals.
Bharat Biotech ... permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
The Delhi government inked a memorandum of understanding (MoU) with the Centre on Saturday to implement the Ayushman Bharat ...